iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
0.6380
-0.0360 (-5.34%)
At close: Nov 6, 2025, 4:00 PM EST
0.6200
-0.0180 (-2.82%)
After-hours: Nov 6, 2025, 5:58 PM EST
iSpecimen Market Cap
iSpecimen has a market cap or net worth of $3.55 million as of November 6, 2025. Its market cap has decreased by -14.07% in one year.
Market Cap
3.55M
Enterprise Value
3.26M
1-Year Change
-14.07%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since the IPO on June 17, 2021, iSpecimen's market cap has decreased from $50.15M to $3.55M, a decrease of -92.93%. That is a compound annual growth rate of -45.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 3.73M | 46.08% |
| Dec 31, 2024 | 2.56M | -43.75% |
| Dec 29, 2023 | 4.54M | -62.95% |
| Dec 30, 2022 | 12.26M | -81.98% |
| Dec 31, 2021 | 68.07M | 35.75% |
| Jun 17, 2021 | 50.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 853.94B |
| Johnson & Johnson | 449.09B |
| AbbVie | 380.54B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 216.33B |
| Novo Nordisk | 215.64B |